bf/NASDAQ:CADL_icon.jpeg

NASDAQ:CADL

Candel Therapeutics, Inc.

  • Stock

USD

Last Close

14.00

16/05 20:00

Market Cap

34.85M

Beta: -

Volume Today

1.02M

Avg: 28.77K

PE Ratio

−2.46

PFCF: −1.09

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
569.50K
-
1.26M
120.46%
985K
21.55%
401K
59.29%
average receivables
book value per share
-0.43
-
-1.26
192.62%
3.40
369.92%
-3.44
201.16%
0.44
112.81%
capex per share
-0.01
-
-0.08
826.69%
-0.10
23.28%
-0.04
53.72%
-0.02
64.90%
capex to depreciation
-3.70
-
-16.22
338.65%
-7.91
51.24%
-1.67
78.92%
-0.38
77.16%
capex to operating cash flow
0.03
-
0.16
429.80%
0.08
49.24%
0.04
50.02%
0.01
67.67%
capex to revenue
-1.27
-
-11.81
828.30%
-14.68
24.32%
-10.38
29.32%
cash per share
2.41
-
1.87
22.34%
4.38
133.78%
2.43
44.49%
1.22
49.65%
days of inventory on hand
days payables outstanding
128.36
-
days sales outstanding
debt to assets
0.01
-
0.02
170.07%
0.01
74.60%
0.29
4,574.82%
0.52
78.04%
debt to equity
-0.05
-
-0.04
23.16%
0.01
121.75%
-0.23
2,735.30%
1.71
843.00%
dividend yield
earnings yield
-0.06
-
-0.17
176.21%
-0.25
44.81%
-0.06
77.34%
-0.89
1,505.70%
enterprise value
126.01M
-
96.89M
23.11%
65.51M
32.39%
4.34M
93.38%
29.88M
589.20%
enterprise value over ebitda
-16.63
-
-11.41
31.36%
-2.68
76.49%
-0.08
96.83%
-0.80
845.91%
ev to operating cash flow
-24.34
-
-10.68
56.12%
-2.95
72.40%
-0.14
95.32%
-0.87
532.34%
ev to sales
1.01K
-
775.15
23.11%
524.04
32.39%
34.69
93.38%
free cash flow per share
-0.29
-
-0.56
97.31%
-1.27
126.14%
-1.14
10.94%
-1.20
5.66%
free cash flow yield
-0.04
-
-0.08
97.31%
-0.16
102.43%
-0.63
289.08%
-0.82
28.66%
graham net net
-0.48
-
-1.43
201.11%
3.05
313.09%
1.39
54.42%
0.22
83.95%
graham number
2.04
-
5.79
184.30%
12.11
108.97%
2.77
77.09%
3.60
29.98%
income quality
0.63
-
0.51
18.34%
0.62
19.88%
1.67
171.81%
0.90
46.01%
intangibles to total assets
0
-
0
0
0
0
interest coverage
-485.40
-
-70.86
85.40%
14.79
120.88%
interest debt per share
0.02
-
0.05
124.85%
0.03
35.75%
0.81
2,387.74%
0.66
17.91%
inventory turnover
invested capital
-0.05
-
-0.04
23.16%
0.01
121.75%
-0.23
2,735.30%
1.71
843.00%
market cap
130.77M
-
131.00M
0.17%
147.59M
12.66%
51.59M
65.04%
42.53M
17.56%
net current asset value
-8.73M
-
-26.70M
205.85%
59.88M
324.28%
41.97M
29.91%
7.84M
81.32%
net debt to ebitda
0.63
-
4.02
539.78%
3.36
16.32%
0.93
72.46%
0.34
63.26%
net income per share
-0.43
-
-1.18
176.21%
-1.92
61.78%
-0.10
94.81%
-1.31
1,218.65%
operating cash flow per share
-0.28
-
-0.48
74.91%
-1.18
142.87%
-1.09
7.41%
-1.18
8.57%
payables turnover
2.84
-
receivables turnover
research and ddevelopement to revenue
52.86
-
70.03
32.50%
121.42
73.38%
166.30
36.95%
return on tangible assets
-0.17
-
-0.58
231.76%
-0.41
29.98%
-0.04
90.90%
-0.91
2,366.17%
revenue per share
0.01
-
0.01
0.17%
0.01
0.84%
0.00
34.52%
roe
1.00
-
0.94
5.61%
-0.56
159.94%
0.03
105.13%
-2.98
10,391.89%
roic
1.15
-
0.77
33.62%
-0.40
152.00%
0.07
117.89%
-1.08
1,618.00%
sales general and administrative to revenue
20.44
-
41.45
102.78%
85.38
106.00%
112.48
31.73%
shareholders equity per share
-0.43
-
-1.26
192.62%
3.40
369.92%
-3.44
201.16%
0.44
112.81%
stock based compensation to revenue
3.20
-
16.86
426.75%
23.70
40.63%
18.46
22.14%
tangible asset value
-8.04M
-
-23.56M
193.13%
64.14M
372.21%
47.71M
25.61%
12.74M
73.29%
tangible book value per share
-0.43
-
-1.26
192.62%
3.40
369.92%
1.66
51.29%
0.44
73.39%
working capital
43.80M
-
30.43M
30.52%
79.58M
161.50%
66.33M
16.65%
22.61M
65.91%

All numbers in USD (except ratios and percentages)